[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627740":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":57,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":25,"enrollmentInfo":74,"targetDuration":25,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Swansea University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Hesperidin","ACTIVE_COMPARATOR","Participants receiving Hesperidin capsules for 12 weeks.",[13],"Dietary Supplement: Hesperidin",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo Comparator","PLACEBO_COMPARATOR","Participants receiving matching placebo capsules for 12 weeks.",[19],"Dietary Supplement: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DIETARY_SUPPLEMENT","500 mg\u002Fday Hesperidin capsules for 12 weeks",[9],null,{"type":22,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Placebo","Matching maltodextrin capsules for 12 weeks.",[15],[31],{"name":32,"affiliation":5,"role":33},"Hayley A Young, PHD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Hayley Young, PhD","CONTACT","+44 (0) 1792 295908","h.a.young@swansea.ac.uk",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"FHMLS, Nutrition Lab","RECRUITING","Swansea","Wales","SA2 8PP","United Kingdom","UK",{"type":50,"coordinates":51},"Point",[52,53],-3.94323,51.62079,{"lat":53,"lon":52},[56],{"name":32,"role":37,"phone":38,"phoneExt":25,"email":39},{"type":33,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Dr Hayley Young","Professor",[61],{"name":62,"class":63},"BioActor B.V.","INDUSTRY","100627740","hesperidin-rct-in-ms-100627740",false,"NCT07452562","Hesperidin RCT in MS","A Randomized, Placebo-Controlled Trial of Hesperidin for Fatigue,Mood, and Cognitive Function in Multiple Sclerosis","NECTAR-MS","Inclusion Criteria:\n\n* Diagnosis of Multiple Sclerosis, Aged 18 years or older.\n\nExclusion Criteria:\n\n* Known food allergies, intolerances, or significant gastrointestinal (GI) problems, Participants under the age of 18 years.","ALL","18 Years",{"count":75,"type":76},60,"ESTIMATED","INTERVENTIONAL",[79],"NA","This study is a randomised, double-blind, placebo-controlled trial investigating the effects of Hesperidin supplementation on cognitive function, fatigue, and stress.\n\nParticipants will be randomly assigned to receive either 500mg of Hesperidin or a matching placebo daily for 12 weeks. The primary outcome is fatigue, with secondary outcomes including cognitive performance and mood. The trial seeks to determine if this dietary intervention offers symptom-alleviating benefits.",[82],"Multiple Sclerosis",[84],"RCT; Hesperidin; Diet","2026-02-28",{"date":87,"type":88},"2026-03-05","ACTUAL",{"date":90,"type":88},"2026-01-07",{"date":92,"type":76},"2027-01-18",{"name":5,"class":6},1]